Cargando…
Using ASMase Knockout Mice to Model Human Diseases
Acid sphingomyelinase (ASMase) is a key initiator of sphingomyelin/ceramide signal transduction activated by many stress stimuli. Over the past two decades, much progress has been made in defining the clinical relevance of sphingomyelin/ceramide signaling in numerous diseases using ASMase knockout m...
Autores principales: | Hua, Guoqiang, Kolesnick, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121422/ https://www.ncbi.nlm.nih.gov/pubmed/23563650 http://dx.doi.org/10.1007/978-3-7091-1511-4_2 |
Ejemplares similares
-
Mitochondrial cholesterol accumulation in alcoholic liver disease: Role of ASMase and endoplasmic reticulum stress
por: Marí, Montserrat, et al.
Publicado: (2014) -
Alpha‐mangostin improves endothelial dysfunction in db/db mice through inhibition of aSMase/ceramide pathway
por: Jiang, Meng, et al.
Publicado: (2021) -
Administration of an Acidic Sphingomyelinase (ASMase) Inhibitor, Imipramine, Reduces Hypoglycemia-Induced Hippocampal Neuronal Death
por: Kho, A Ra, et al.
Publicado: (2022) -
Targeting the ASMase/S1P pathway protects from sortilin-evoked vascular damage in hypertension
por: Di Pietro, Paola, et al.
Publicado: (2022) -
Ultrasound-stimulated microbubbles enhanced vascular disruption in fractionated radiotherapy-treated tumours via ASMase activation
por: Leong, Kai Xuan, et al.
Publicado: (2023)